Alkaloids from Coptis chinensis root promote glucose uptake in C2C12 myotubes

Fitoterapia

Volumn 93, Issue , 2014, Pages 239-244

  Yang, Te Chun ^a   Chao, Hsin Fan ^b   Shi, Li Shian ^c   Chang, Tsu Chung ^b   Lin, Hang Ching ^b,d   Chang, Wen Liang ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c NATIONAL FORMOSA UNIVERSITY   (Taiwan)

^d Sinpharm Pharmaceutical Incorporated I Lan   (Taiwan)

Author keywords

Alkaloid; C2C12 cells; Coptis chinensis; Glucose uptake; Skeletal muscle

Indexed keywords

ALKALOID; ANTIDIABETIC AGENT; GLUCOSE; PLANT EXTRACT;

ANIMAL; CELL LINE; CHEMISTRY; COPTIS; DIABETES MELLITUS; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; MOUSE; PHYTOTHERAPY; PLANT ROOT; SKELETAL MUSCLE;

ALKALOIDS; ANIMALS; CELL LINE; COPTIS; DIABETES MELLITUS; GLUCOSE; HYPOGLYCEMIC AGENTS; MICE; MUSCLE FIBERS, SKELETAL; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PLANTS, MEDICINAL;

EID: 84893785995     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2014.01.008     Document Type: Article

References (36)

1. G. Danaei, M.M. Finucane, Y. Lu, G.M. Singh, M.J. Cowan, and C.J. Paciorek et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants Lancet 378 2011 31 40
2. World Health Organization Global status report on noncommunicable diseases 2010 [Geneva]
3. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 2568 2569 (Pubitemid 39281428)
4. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: diagnosis and classification of diabetes mellitus 1999 [Geneva, WHO/NCD/NCS/99.2]
5. S. Mudaliar, and R.R. Henry Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial function Am J Med 123 2010 S19 S27
6. R.A. DeFronzo, R.C. Bonadonna, and E. Ferrannini Pathogenesis of NIDDM: a balanced overview Diabetes Care 15 1992 318 368
7. Y.T. Kruszynska, and J.M. Olefsky Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus J Invest Med 44 1996 413 428 (Pubitemid 126820690)
8. W. Tang, and G. Eisenbrand Coptis spp.Chinese drugs of plant origin 1992 Springer-Verlag New York 361 371
9. J.K. Chen, and T.T. Chen Chinese medical herbology and pharmacology 2004 Art of Medicine Press City of Industry, CA
10. H.J. Wang, and B.H. Chiang Anti-diabetic effect of a traditional Chinese medicine formula J Funct Foods 3 2012 1161 1169
11. W. Jia, W.Y. Gao, and L. Tang Antidiabetic herbal drugs officially approved in China Phytother Res 17 2003 1127 1134 (Pubitemid 38057166)
12. M. Ou Chinese-English manual of common-used traditional medicine 1992 Guangdong Science and Technology Publishing House Guangzhou 548 549
13. E.K. Park, H.I. Rhee, H.S. Jung, S.M. Ju, Y.A. Lee, and S.H. Lee et al. Antiinflammatory effects of a combined herbal preparation (RAH13) of Phellodendron amurense and Coptis chinensis in animal models of inflammation Phytother Res 21 2007 746 750
14. L. Chen, L. Wang, Q. Zhang, S. Zhang, and W. Ye Non-alkaloid chemical constituents from Coptis chinensis Zhongguo Zhong Yao Za Zhi 37 2012 1241 1244
15. B. Zhang, A. Cao, J. Zhou, Z. Hu, and D. Wu Effect of jatrorrhizine on delayed gastrointestinal transit in rat postoperative ileus J Pharm Pharmacol 64 2012 413 419
16. P.L. Tsai, and T.H. Tsai Hepatobiliary excretion of berberine Drug Metab Dispos 32 2004 405 412
17. C.C. Lin, L.T. Ng, F.F. Hsu, D.E. Shieh, and L.C. Chiang Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth Clin Exp Pharmacol Physiol 31 2004 65 69 (Pubitemid 38230750)
18. L. Varinska, L. Mirossay, G. Mojzisova, and J. Mojzis Antiangogenic effect of selected phytochemicals Pharmazie 65 2012 57 63
19. S.H. Leng, F.E. Lu, and L.J. Xu Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion Acta Pharmacol Sin 25 2004 496 502
20. W.J. Kong, J. Wei, P. Abidi, M. Lin, S. Inaba, and C. Li et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins Nat Med 10 2004 1344 1351 (Pubitemid 40022716)
21. S. Bae, and Y. Yoon Anti-adipogenic activity of berberine is not mediated by the WNT/β-catenin pathway Phytother Res 27 2013 937 943
22. F. Yang, T. Zhang, R. Zhang, and Y. Ito Application of analytical and preparative high-speed counter-current chromatography for separation of alkaloids from Coptis chinensis Franch. J Chromatogr 829 1998 137 141 (Pubitemid 29005085)
23. H. Yan, X. Sun, S. Sun, S. Wang, J. Zhang, and R. Wang et al. Anti-ultraviolet radiation effects of Coptis chinensis and Phellodendron amurense glycans by immunomodulating and inhibiting oxidative injury Int J Biol Macromol 48 2011 720 725
24. A. Guilherme, J.V. Virbasius, V. Puri, and M.P. Czech Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes Nat Rev Mol Cell Biol 9 2008 367 377 (Pubitemid 351574198)
25. G. Lattanzi, A. Ognibene, P. Sabatelli, C. Capanni, D. Toniolo, and M. Columbaro et al. Emerin expression at the early stages of myogenic differentiation Differentiation 66 2000 208 217 (Pubitemid 32046923)
26. M. Shamma, M.J. Hillman, and C.D. Jones The UV spectra of protoberberines Chem Rev 69 1969 779 784
27. Y.D. Min, M.C. Yang, K.H. Lee, K.R. Kim, S.U. Choi, and K.R. Lee Protoberberine alkaloids and their reversal activity of P-gp expressed multi drug resistance (MDR) from the rhizome of Coptis japonica Makino Arch Pharm Res 29 2006 757 761
28. W. Wang, Q.W. Zhang, Y.T. Wang, W. Wang, and W.C. Ye Isoquinoline alkaloids from the rhizoma of Coptis chinensis Chin J Nat Med 5 2007 348 350 (Pubitemid 47570421)
29. H.A. Jung, N.Y. Yoon, H.J. Bae, B.S. Min, and J.S. Choi Inhibitory activities of the alkaloids from coptidis rhizoma against aldose reductase Arch Pharm Res 31 2008 1405 1412
30. J.S. Zhang, L.M.O. Louisette, and G. Massiot Isoquinoline alkaloids from Acangelisia gusanlung Phytochemistry 39 1995 439 442
31. K. Nishimura, Y. Takenaka, M. Kishi, T. Tanahashi, H. Yoshida, and C. Okuda et al. Synthesis and DNA polymerase α and β inhibitory activity of alkyl p-coumarates and related compounds Chem Pharm Bull 57 2009 476 480
32. V. Chantimakorn, and S. Nimgirawath Syntheses of the benzylisoquinoline alkaloids isosevanine and berbithine Aust J Chem 42 1989 209 213
33. P.B. Wakchaure, and N.P. Argade Intramolecular chemoselective acylation of a suitably substituted isoindole: synthesis of (±)-chilenine and (±)-deoxychilenine J Org Chem 17 2011 2838 2842
34. T.S. Wu, M.Y. Hsu, P.C. Kuo, B. Sreenivasulu, A.G. Damu, and C.R. Su et al. Constituents from the leaves of Phellodendron amurense var. Wilsonii and their bioactivity J Nat Prod 66 2003 1207 1211 (Pubitemid 37204220)
35. Q. Zhang, X.H. Xiao, K. Feng, T. Wang, W.H. Li, and T. Yuan et al. Berberine moderates glucose and lipid metabolism through multipathway mechanism Evid Based Complement Altern Med 2011 10.1155/2011/924851
36. J. Yin, H. Zhang, and J.P. Ye Traditional Chinese medicine in treatment of metabolic syndrome Endocr Metab Immune Disord Drug Targets 8 2008 99 111